Benjamin F. Edwards & Company’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-280	Closed	-$13K	–	1902
2019 Q4	$13K	Sell	280 -174	-38%	-$6.9K	﹤0.01%	1361
2019 Q3	$16K	Sell	454 -90	-17%	-$3.35K	﹤0.01%	1269
2019 Q2	$22K	Hold	544	–	–	﹤0.01%	1167
2019 Q1	$23K	Hold	544	–	–	﹤0.01%	1101
2018 Q4	$20K	Hold	544	–	–	﹤0.01%	1094
2018 Q3	$26K	Hold	544	–	–	﹤0.01%	1056
2018 Q2	$23K	Hold	544	–	–	﹤0.01%	1064
2018 Q1	$23K	Hold	544	–	–	﹤0.01%	1038
2017 Q4	$24K	Hold	544	–	–	﹤0.01%	974
2017 Q3	$23K	Hold	544	–	–	﹤0.01%	951
2017 Q2	$23K	Hold	544	–	–	﹤0.01%	875
2017 Q1	$23K	Sell	544 -74	-12%	-$3.02K	﹤0.01%	834
2016 Q4	$24K	Hold	618	–	–	﹤0.01%	749
2016 Q3	$27K	Sell	618 -730	-54%	-$33.1K	﹤0.01%	657
2016 Q2	$56K	Hold	1,348	–	–	0.01%	496
2016 Q1	$54K	Hold	1,348	–	–	0.01%	489
2015 Q4	$69K	Sell	1,348 -12,969	-91%	-$661K	0.01%	463
2015 Q3	$672K	Sell	14,317 -81	-0.6%	-$4.88K	0.15%	149
2015 Q2	$898K	Sell	14,398 -394	-3%	-$24.5K	0.18%	122
2015 Q1	$913K	Sell	14,792 -2,584	-15%	-$153K	0.19%	118
2014 Q4	$938K	Buy	17,376 +1,298	+8%	+$70.9K	0.22%	106
2014 Q3	$852K	Hold	16,078	–	–	0.21%	113
2014 Q2	$834K	Sell	16,078 -3,042	-16%	-$147K	0.21%	112
2014 Q1	$895K	Sell	19,120 -336	-2%	-$15.9K	0.25%	99
2013 Q4	$856K	Sell	19,456 -354	-2%	-$14.7K	0.29%	89
2013 Q3	$762K	Buy	19,810 +488	+3%	+$18.5K	0.28%	99
2013 Q2	$681K	Buy	+19,322	New	+$652K	0.27%	96

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

FMP

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Benjamin F. Edwards & Company's XPH Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2020, closing a stake of 280 shares — an estimated $13K sold.

Benjamin F. Edwards & Company first reported a position in XPH in Q2 2013 and held it in 27 quarters. The position peaked at $938K in Q4 2014. 66 funds tracked by Wall St. Rank hold XPH as of Q1 2020.

Benjamin F. Edwards & Company reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
Benjamin F. Edwards & Company sold 280 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2020, an estimated $13K.
Benjamin F. Edwards & Company first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 27 quarters.
Benjamin F. Edwards & Company's State Street SPDR S&P Pharmaceuticals ETF position peaked at $938K in Q4 2014.
66 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.